Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
The Journal of Clinical Investigation
|
July 15, 2010
Activating transcription factor 4 regulates osteoclast differentiation in mice
Huiling Cao, Shibing Yu, Zhi Yao, et al.
Science Advances
|
December 10, 2021
Targeting metabotropic glutamate receptor 4 for cancer immunotherapy
Zhuoya Wan, Runzi Sun, Yang-Wuyue Liu, et al.
Iscience
|
May 21, 2026
Bi-functional anti-LAG-3-IL-2c enhances immune checkpoint inhibitor and CAR T-cell therapy for cancer
Fang Huang, Jianing Huang, Fan Ye, et al.
Medcomm
|
August 27, 2025
Identification of c-Met on Tumor Cells as a Novel Receptor for B7-H3 Entails Implications for Cancer Cell Stemness and Targeted Therapy
Lei Cao, Yunyun Xu, Yizhou Hu, et al.
Journal of Immunology Research
|
March 28, 2022
Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis
Peijun Tang, Xingnian Chen, Junchi Xu, et al.
Nature Immunology
|
February 20, 2019
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
Clémence Hollande, Jeremy Boussier, James Ziai, et al.
Science Advances
|
December 8, 2022
Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response
Yifei Wang, Yueshan Zhao, Weiwei Guo, et al.
Cell Reports
|
May 10, 2018
ATF4 Regulates CD4<sup>+</sup> T Cell Immune Responses through Metabolic Reprogramming
Xi Yang, Rui Xia, Cuihua Yue, et al.
Hepatology Communications
|
January 4, 2022
Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma
Yang Xie, Runzi Sun, Li Gao, et al.
Nature Communications
|
January 4, 2024
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy
Zhangyi Luo, Yixian Huang, Neelu Batra, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
The Journal of Clinical Investigation
|
July 15, 2010
Activating transcription factor 4 regulates osteoclast differentiation in mice
Huiling Cao, Shibing Yu, Zhi Yao, et al.
Science Advances
|
December 10, 2021
Targeting metabotropic glutamate receptor 4 for cancer immunotherapy
Zhuoya Wan, Runzi Sun, Yang-Wuyue Liu, et al.
Iscience
|
May 21, 2026
Bi-functional anti-LAG-3-IL-2c enhances immune checkpoint inhibitor and CAR T-cell therapy for cancer
Fang Huang, Jianing Huang, Fan Ye, et al.
Medcomm
|
August 27, 2025
Identification of c-Met on Tumor Cells as a Novel Receptor for B7-H3 Entails Implications for Cancer Cell Stemness and Targeted Therapy
Lei Cao, Yunyun Xu, Yizhou Hu, et al.
Journal of Immunology Research
|
March 28, 2022
Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis
Peijun Tang, Xingnian Chen, Junchi Xu, et al.
Nature Immunology
|
February 20, 2019
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
Clémence Hollande, Jeremy Boussier, James Ziai, et al.
Science Advances
|
December 8, 2022
Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response
Yifei Wang, Yueshan Zhao, Weiwei Guo, et al.
Cell Reports
|
May 10, 2018
ATF4 Regulates CD4<sup>+</sup> T Cell Immune Responses through Metabolic Reprogramming
Xi Yang, Rui Xia, Cuihua Yue, et al.
Hepatology Communications
|
January 4, 2022
Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma
Yang Xie, Runzi Sun, Li Gao, et al.
Nature Communications
|
January 4, 2024
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy
Zhangyi Luo, Yixian Huang, Neelu Batra, et al.
Page
of 12